Table 2. Summary of the immunoassay validation data provided by kit manufacturers.
| Analyte, unit |
Reagent/ Manufacturer |
Assay range |
Limit of quantification |
Total precision, CV % | Recovery, % |
|---|---|---|---|---|---|
| Aldosterone, nmol/L | Liaison Aldosterone/ DiaSorin |
0.027–2.77 | 0.053 | 9.5% | 91% |
| Cortisol, µmol/L | Alinity i Cortisol/ Abbott |
0.028–1.650 | 0.028 | 3.7% | n.a. |
| DHEAS, µmol/L | Architect DHEA-S/ Abbott |
0.08–40.71 | n.a. | 7.41% | 102% |
| Testosterone, nmol/L | Architect 2nd gen Testosterone/Abbott |
0.13–64.57 | 0.15 | 4.6% | n.a. |
| Progesterone, nmol/L | Alinity i Progesterone/ Abbott |
1.6–127.2 | 1.6 | 5.8% | n.a. |
| Architect Progesterone/ Abbott |
n.a.–127.2 | n.a. | 6.2% | 96% | |
| OHP, nmol/L | 17-OH-progesterone/ DIAsource |
0.10–60.52 | n.a. | n.a. | 105% |
| DHEAS - dehydroepiandrosterone sulfate. OHP - 17-hydroxyprogesterone. n.a. = not available | |||||